Wonbiogen Co Ltd
KOSDAQ:307280
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orbia Advance Corporation SAB de CV
BMV:ORBIA
|
MX |
|
SKM Egg Products Export India Ltd
NSE:SKMEGGPROD
|
IN |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (6), the stock would be worth ₩3 186.24 (47% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4 | ₩2 165 |
0%
|
| 3-Year Average | 6 | ₩3 186.24 |
+47%
|
| 5-Year Average | 7.2 | ₩3 866.03 |
+79%
|
| Industry Average | 13.6 | ₩7 267.9 |
+236%
|
| Country Average | 10 | ₩5 342.93 |
+147%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
W
|
Wonbiogen Co Ltd
KOSDAQ:307280
|
49.2B KRW | 4 | 7.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170B USD | 54.1 | 59.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
160.6B USD | 16.9 | 25.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.1B USD | 27.2 | 38.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD | 17.4 | 23.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
97.4B USD | 23.6 | 33.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 15.8 | 19.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 26.5 | 43.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 38.1 | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 17.7 | 25.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
31.9B USD | 18.6 | 15.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 5.8 |
| Median | 10 |
| 70th Percentile | 18.7 |
| Max | 2 215 163.4 |
Other Multiples
Wonbiogen Co Ltd
Glance View
Wonbiogen Co., Ltd. engages in the research and development of biocompatible medical materials. The company is headquartered in Gumi, Gyeongsangbuk-Do. The company went IPO on 2018-12-05. The firm provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.
